Big Sioux Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-7
Closed -$1.69K – 248
2026
Q2
$1.69K Hold
7
– – ﹤0.01% 347
2026
Q1
$1.32K Hold
7
– – ﹤0.01% 345
2025
Q4
$1.19K Buy
+7
New +$1.07K ﹤0.01% 348

Other funds holding JAZZ

Big Sioux Wealth Management's JAZZ Position: Q3 2026 in Review

Big Sioux Wealth Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2026, closing a stake of 7 shares — an estimated $1.69K sold.

Big Sioux Wealth Management first reported a position in JAZZ in Q4 2025 and held it in 3 quarters. The position peaked at $1.69K in Q2 2026. 672 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Big Sioux Wealth Management reported no remaining Jazz Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Big Sioux Wealth Management sold 7 Jazz Pharmaceuticals shares in Q3 2026, an estimated $1.69K.
  • Big Sioux Wealth Management first reported a position in Jazz Pharmaceuticals in Q4 2025 and held it in 3 quarters.
  • Big Sioux Wealth Management's Jazz Pharmaceuticals position peaked at $1.69K in Q2 2026.
  • 672 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Big Sioux Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.